Introduction
============

Acute kidney injury (AKI) is a common problem in critically ill patients, and AKI-induced organ inflammation and tubular fibrosis represent a major risk factor for the development of end-stage renal failure.[@b1-jir-10-135] Efforts aimed at reducing AKI incidence and improving its clinical management may benefit patients' survival and delay the initiation of dialysis with all the related complications.[@b2-jir-10-135],[@b3-jir-10-135] Despite advances in intensive care, renal replacement therapy techniques[@b4-jir-10-135] and decrease in in-hospital mortality,[@b5-jir-10-135] effective treatments to preserve renal function after AKI have not been developed yet and outcomes have not changed significantly over time.[@b6-jir-10-135]

During injury, tubular cell death, changes in filtration barrier, glomerular misfiltration, vasoconstriction and tubular obstruction, as well as proliferation of mesangial cells and proliferative/apoptotic damage of podocytes usually occur.[@b7-jir-10-135]--[@b9-jir-10-135] Various models of renal inflammation and ischemia have highlighted a role of reactive oxygen species (ROS) in glomerular injury. During the oxidative damage, mesangial cells induce cell death or hyperproliferation and accumulation of extracellular matrix in the surviving population, thus initiating kidney fibrosis.[@b10-jir-10-135],[@b11-jir-10-135] Therefore, therapeutic approaches targeting inhibition of mesangial cell proliferation may provide promising opportunities to prevent fibrosis and defend the kidney from concomitant damages during inflammation.

We have recently demonstrated the ability of a differentiating agent, an ester of hyaluronic acid and butyric acid (HB), to enhance the regenerative processes of the kidney after induction of ischemia/reperfusion injury. In our previous ischemic AKI rat model, treatment with HB-preconditioned mesenchymal stem cells accelerated renal function recovery and resulted in a minor degree of inflammation, thus promoting the restoration of the damaged tissue.[@b12-jir-10-135]

The bioactivity of HB, a four-carbon chain fatty acid (CH~3~CH~2~CH~2~COOH), is related to its ability to modify nuclear architecture, to induce apoptosis and to change the structure of chromatin through modulation of post-translational modifications involved in metabolic activities and different signal pathways, namely, cell differentiation, proliferation, motility, induction of cell-cycle arrest and apoptosis.[@b13-jir-10-135]--[@b19-jir-10-135] More recent studies have described a further biological role of butyrate as an inhibitor of histone deacetylases (HDACs), a class of enzymes involved in several biological pathways: fibroblast proliferation, chemokine production and regulation of the expression of connective tissue growth factor (CTGF), collagen and α-smooth muscle actin (α-SMA) in interstitial renal fibroblast and tubular epithelial cells.[@b20-jir-10-135]

Previous findings from our group highlighted the enhanced efficacy of hyaluronan monoesters with butyric acid to promote the recovery of damaged tubular epithelial cells or the differentiation and proliferation of potential residential stem cells.[@b12-jir-10-135],[@b21-jir-10-135],[@b22-jir-10-135] The rationale for the use of hyaluronate, rather than butyrate alone, lies in its efficiency as a targeting system, through its receptor CD44, expressed on several cell types. The ligand--receptor interaction allows the internalization of the transported molecules, including butyric acid.[@b23-jir-10-135]

Here, we analyzed in vitro the potential protective role of HB on proliferation, death and matrix deposition of mesangial cells exposed to oxidative stress in order to evaluate the possibility of using this molecule to prevent the progression of AKI into organ fibrosis.

Materials and methods
=====================

Experimental model
------------------

### Cell culture

Two-day-old male Wistar rats were provided by Charles River Laboratories, Inc. (Lecco, Italy). The use of animals and all animal procedures used in this study was approved by the local bioethics committee of the University of Bologna. The procedures conformed to the protocols of the local Bioethics Committee of Nephrology Department of the University, number 02/2010.

Kidneys were removed aseptically and homogenized in Hanks' solution, and mesangial cells were extracted as previously described.[@b24-jir-10-135] The small cubes of renal cortex tissue were washed three times with Hanks' Balanced Salt Solution (HBSS; Invitrogen/Gibco, Carlsbad, CA, USA), minced and passed through sieves to isolate glomeruli. Next, glomeruli were digested by a solution containing 0.1% collagenase IV at 37°C and centrifuged at 400× *g* for 5 min. The pellets were resuspended in Roswell Park Memorial Institute (RPMI) 1640 with 10% fetal bovine serum. The released cells were then cultured in RPMI 1640 medium (Lonza, Basel, Switzerland) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin (all purchased from EuroClone, Pero, Italy) and 5 μg/mL each of insulin (Sigma-Aldrich Co., St Louis, MO, USA). A total of 50 μM H~2~O~2~ was used to simulate in vitro ischemia/reperfusion injury. To evaluate the effect of HB treatment in the prevention of H~2~O~2~ damage, cells were divided into three groups: HB--H~2~O~2~ group: mesangial cells pretreated with HB (1 g/L) for 24 h, before adding H~2~O~2~H~2~O~2~ group: cells untreated with HB before adding H~2~O~2~Negative control group: cells not treated with HB or H~2~O~2~

### Lactate dehydrogenase assay

H~2~O~2~ toxicity was assessed by measuring the lactate dehydrogenase (LDH) released in culture media at 2, 6, 16 and 24 h after H~2~O~2~ treatment using Cell Toxicity Colorimetric Assay Kit (Sigma-Aldrich Co.). The results were expressed as percentage of viable cells versus untreated control cells. In order to distinguish apoptosis from necrosis, 20 μM *N*-acetyl-Asp-Glu-Val-Asp-aldehyde (DEVD-CHO), a caspase-3-preferred peptide inhibitor, was added to the cells for 1 h prior to H~2~O~2~. To evaluate HB toxicity, an aliquot of cell culture was treated only with HB and no addition of H~2~O~2~.

### Caspase-3 activity assay

The activity of caspase-3 was determined by Caspase Colorimetric Assay Kit (Sigma-Aldrich Co.) according to the manufacturer's protocol. Briefly, cells were collected and lyzed in the lysis buffer provided with the kit. Caspase-3 substrate was added to each well. The hydrolysis of the peptide substrate acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA) by caspase-3 results in the release of the p-nitroaniline (pNA) moiety. The chromophore pNA was detected using a spectrophotometer at a wavelength of 405 nm. The caspase enzymatic activity in cell lysates was directly proportional to the color reaction.

### Viability assay

The thiazolyl blue (MTT) assay (Boehringer Mannheim, Indianapolis, IN, USA) was performed to evaluate viability of cells. Cells were cultured for 6, 16, 24, 48 and 72 h and analyzed according to the manufacturer's instructions. Cytotoxicity was calculated by expressing experimental absorbance values as percentage of control values (untreated cells).

### Cell-cycle analysis

Cells were collected after H~2~O~2~ treatment, resuspended in phosphate-buffered saline (PBS) at a final concentration of 1 × 10^6^ cells/mL and then fixed with Trisodium Citrate (1 mg/mL), NaCl (0.5 mg/mL), Nonidet P40 (300 μg/L) and 10 μg/mL ribonuclease A (RNase A) for 1 h at 4°C. Next, citric acid (15 mg/mL) and saccarose (85 mg/mL) were added, and the cells were incubated for 45 min. Fixed cells were stained with propidium iodide (PI) for 30 min at room temperature in the dark and analyzed by a FACSAria flow cytometer (BD Biosciences, San Jose, CA, USA).

### Western blot

Mesangial cell lysates were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). P-p38, P-Akt and GAPDH were detected by incubation with polyclonal rabbit P-p38 specific antibody (1:500 dilution; Santa Cruz Biotechnology Inc., Dallas, TX, USA), polyclonal rabbit P-Akt antibody (1:2000 dilution; Cell Signaling Technology, Danvers, MA, USA) and a monoclonal rabbit GAPDH-specific antibody (1:1000 dilution; Cell Signaling Technology), respectively.

### Gene expression

Gene expression of collagen 1 alpha and MMP-9 was analyzed at 2, 6, 16 and 24 h after H~2~O~2~ treatment. Total RNA was extracted from the cultured mesangial cells using TRIzol Reagent (Invitrogen), according to the manufacturer's directions. Following reverse transcription, \~20 ng of cDNA was relatively quantified by quantitative polymerase chain reaction (qPCR) using SYBR Green FastStart Kit (Lightcycler FastStart DNA Master^PLUS^ SYBR Green I; Roche Applied Science, Penzberg, Germany) on a LightCycler System (Roche). The primers were predesigned by QuantiTect Primer Assays (Qiagen, Hilden, Germany), and gene expression from quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) data was normalized using GAPDH as a housekeeping gene.

Statistical analysis
--------------------

Data are presented as mean ± standard error of the mean (SEM). Two-sided Student's *t*-test for independent samples was used to evaluate the different effects of the treatment between groups. Comparison of more than two groups was performed by one-way analysis of variance (ANOVA), followed by Bonferroni post hoc test. A *p*-value \<0.05 was assumed as the limit of significance. Data analysis was performed using GraphPad Prism for Windows software (GraphPad Software, Inc., La Jolla, CA, USA).

Results
=======

Effect of HB treatment on cell viability
----------------------------------------

A significant increased release of LDH into the medium was observed in cells added with H~2~O~2~ without HB pretreatment (H~2~O~2~ group), which at 16 h was two times higher than in untreated negative control cells. At the same time point, the percentage of death cells was significantly lower in the HB--H~2~O~2~ group than in the H~2~O~2~ group. At 24 h, the level of LDH release found in the H~2~O~2~ group was significantly higher in comparison with all the other groups. Later, there was a decrease in the percentage of dead cells until 48 h, probably due to the hyperproliferation of the surviving cells. Pretreatment with DEVD-CHO, an inhibitor of capsase-3, did not reduce cell death rate, suggesting that H~2~O~2~ preferentially induced necrosis. Treatment with HB alone was not toxic as it did not affect LDH release ([Figure 1A](#f1-jir-10-135){ref-type="fig"}). When analyzing apoptosis through caspase-3 activity, we observed that in the presence of DEVD-CHO, caspase-3 was inhibited, whereas pretreatment with HB induced activation with the highest effect observed at 16 h ([Figure 1B](#f1-jir-10-135){ref-type="fig"}).

Taken together, these results indicate that, in the presence of H~2~O~2~, cells died preferentially via necrosis, since cell death was not prevented by the treatment with DEVD-CHO, an inhibitor of caspase-3. Conversely, HB pretreatment reduced cell death rate and activated caspase-3.

Cell cycle was then analyzed to better investigate the doubled release of LDH observed in cells added only with H~2~O~2~. At 24 h, 35% of H~2~O~2~-treated cells were in the G2/S phase, in comparison with 10% of untreated controls and 23% of HB-pretreated cells ([Figure 2](#f2-jir-10-135){ref-type="fig"}).

The results of MTT assay confirmed the protective effect of HB on the death of mesangial cells. H~2~O~2~-treated cells immediately lost their metabolic activity, while HB pretreatment preserved a nearly normal activity till 6 h after H~2~O~2~ treatment. Then, metabolic activity was greatly reduced, but it remained higher than in non-pretreated cells ([Figure 3](#f3-jir-10-135){ref-type="fig"}).

Effect of HB treatment on Akt, p38 phosphorylation and gene expression
----------------------------------------------------------------------

The phosphorylation status of Akt and p38 was detected at 2, 6 and 24 h after the treatment with H~2~O~2~ using Western blot ([Figure 4A](#f4-jir-10-135){ref-type="fig"}). Akt phosphorylation at 2 and 6 h in the H~2~O~2~ group was found to be increased in comparison with untreated control cells, but it was significantly reduced by the pretreatment with HB ([Figure 4B](#f4-jir-10-135){ref-type="fig"}). The level of p38 phosphorylation at 6 and 24 h was significantly higher in HB-pretreated cells compared to the other groups ([Figure 4C](#f4-jir-10-135){ref-type="fig"}).

qPCR showed no differences in collagen 1 alpha gene expression between H~2~O~2~ group and HB--H~2~O~2~ group until 16 h following treatment, and then at 24 h, collagen 1 alpha gene expression was lower in cells that had been pretreated with HB before oxidative stress insult by H~2~O~2~ ([Figure 5B](#f5-jir-10-135){ref-type="fig"}). Conversely, MMP-9 expression was unaffected by H~2~O~2~ alone, while it appeared to be enhanced by HB pretreatment at each time point, even if the difference met statistical significance at 24 h ([Figure 5A](#f5-jir-10-135){ref-type="fig"}).

Discussion
==========

In this study, we investigated the mechanistic role of HB on proliferation, death and matrix deposition of mesangial cells in an in vitro model of AKI after oxidative stress induction. We have previously described in two different in vivo models the ability of hyaluronan esters of butyric acid to enhance the rescuing potential of human mesenchymal stem cells.[@b12-jir-10-135],[@b21-jir-10-135] In spite of the promising results, the need of several weeks to collect and expand cellular cultures leads to a substantial delay for autologous stem cell transplantation and for a timely intervention during the early phases of AKI. We have hypothesized that HB is able to reduce the degree of injury, and it may serve as a first effort to repair a damaged kidney. Here, we designed an in vitro model of oxidative stress to reproduce ischemia/reperfusion injury by exposing mesangial cells to hydrogen peroxide.

In our experimental model, we used a 50 μM concentration of H~2~O~2~ to induce ischemic damage, after testing scalar H~2~O~2~ concentrations (25, 50, 75 and 100 μM) to assess the mortality rate achieved after 24 h of treatment. We found that 24 h vitality was 95% using the 25 μM concentration, 80% with the 50 μM concentration and 40% with the 75 μM concentration, the latter resulting in noticeable damage. An important point is the discrimination of cellular response to H~2~O~2~ insult between necrosis and apoptosis. In cells not previously added with HB, hydrogen peroxide triggered preferentially necrotic cell death, while HB pretreatment reduced LDH release and led to caspase-3 activation, the main effector of apoptosis. Therefore, it seems that HB may predispose mesangial cells to programmed cell death, rather than necrosis, a process commonly associated with inflammation and fibrosis.[@b11-jir-10-135] A peak of LDH release was found 16 h after oxidative stress insult; then, the percentage of dead cells showed a progressive reduction. Interestingly, in cell-cycle analysis, we observed a significant increase in cells of the G2/S phase 24 h after H~2~O~2~ exposure, thus confirming the hypothesis that mesangial cells initially respond to oxidative damage with necrosis and then start to hyperproliferate, in line with previous evidence.[@b11-jir-10-135] HB pretreatment seems to limit the proliferative effect elicited by peroxide on mesangial cells. The role of apoptosis on mesangial biology is still controversial. However, these cells are committed to apoptosis or acquire an activated phenotype in response to metabolic, immunologic or hemodynamic injury and undergo hypertrophy and proliferation with overproduction of matrix proteins, growth factors, chemokines and cytokines. These soluble factors may act through either autocrine or paracrine pathways on mesangial or glomerular cells, respectively.[@b24-jir-10-135] Therefore, a treatment able to switch cell commitment toward apoptosis, to reduce proliferation and to control inflammation after injury may exert a beneficial effect on the damaged tissue. In different animal models of renal failure, kidney injury has been associated with activation of apoptotic signaling. Interestingly, the regression of apoptotic features is concomitant with renal function recovery.[@b25-jir-10-135],[@b26-jir-10-135] Thus, the reversibility of apoptosis may limit inflammation and facilitate tissue restoring.

There is a large body of evidence to indicate that many glomerular diseases are associated with increased activation of PI3-kinase/Akt signaling in mesangial cells. It has been reported that both glomerulosclerosis and albuminuria are worsened in Akt2(−/−) mice as compared to wild-type animals,[@b27-jir-10-135] and podocyte survival and foot process effacement are directly regulated by Akt2 pathway.[@b27-jir-10-135],[@b28-jir-10-135] Diabetic nephropathy is characterized by mesangial cell expansion and extracellular matrix accumulation; in this context, PI3-k/Akt activation via Fox3a phosphorylation induces cellular survival and oxidative stress.[@b29-jir-10-135],[@b30-jir-10-135] Furthermore, hydrogen peroxide has been proven to induce Akt activation in mesangial cells in vitro.[@b31-jir-10-135]

Considering that Akt pathway is usually involved in cell survival and proliferation,[@b32-jir-10-135] our analysis highlighted a significant increase in Akt phosphorylation levels in H~2~O~2~-treated cells compared to controls. However, a similar rise in Akt phosphorylation was found in HB-pretreated cells, suggesting that HB might prevent the activation of survival pathways. Hyperproliferation is often associated with fibrosis, increased matrix deposition and scar formation.[@b33-jir-10-135] The p38 signaling has a key role in the regulation of cell proliferation, extracellular matrix gene expression and apoptosis.[@b34-jir-10-135] In particular, p38 pathway controls gene expression of MMP-9 and MMP-2,[@b35-jir-10-135] matrix metalloproteinases specifically secreted by mesangial cells in normal conditions to control the dynamic turnover of mesangial matrix.[@b36-jir-10-135] An intriguing finding emerging from our study was the increased p38 phosphorylation in HB-pretreated cells and a consistent upregulation of MMP-9 transcription revealed by qPCR analysis. Thus, we postulate a possible mechanism by which HB pretreatment could promote a recovery of mesangial function in extracellular matrix regulation. After the oxidative damage, HB might be able to redirect mesangial cells toward apoptosis and to reduce cellular proliferation; concomitantly, it might activate p38 MAPK pathway and enhance MMP-9 expression.

Conclusion
==========

These preliminary findings might provide a basis for further in vivo studies to better elucidate the rationale for the use of HB in injured kidney to prevent and possibly reverse fibrosis and to promote tissue regeneration.
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![HB treatment induces apoptosis after H~2~O~2~-induced oxidative stress.\
**Notes:** (**A**) LDH release into the medium: H~2~O~2~ treatment induced cell death as demonstrated by high LDH release starting from 16 h; HB had a protective effect, and LDH release was reduced. The pretreatment with DEVD-CHO did not affect LDH release in H~2~O~2~-treated cells, indicating that H~2~O~2~ triggered necrotic cell death. The results are expressed as the percentage of viable cells compared with negative control cells (not treated with HB or H~2~O~2~) referred to as 100%. (**B**) Caspase-3 activity: HB treatment activated caspase-3, while H~2~O~2~ alone did not. Negative control cells are referred as 100%. Data are given as mean ± SEM of three independent experiments. Statistical analysis: one-way ANOVA (n = 3). Significantly different from H~2~O~2~-treated cells (\**p* \< 0.05, \*\**p* \< 0.01 and \*\*\**p* \< 0.001).\
**Abbreviations:** HB, hyaluronic acid and butyric acid; LDH, lactate dehydrogenase; DEVD-CHO, *N*-acetyl-Asp-Glu-Val-Asp-aldehyde; SEM, standard error of the mean; ANOVA, analysis of variance.](jir-10-135Fig1){#f1-jir-10-135}

![HB treatment reduces cellular proliferation after H~2~O~2~-induced oxidative stress.\
**Notes:** Cell-cycle analysis indicated that the percentage of cells in phase G2/S increased after treatment with H~2~O~2~, but it was significantly lower when cells had been pretreated with HB. Untreated cells (not treated with HB or H~2~O~2~) were considered as negative controls. Data are given as mean ± SEM of three independent experiments. Statistical analysis: one-way ANOVA (n = 3). Significantly different from H~2~O~2~ (\**p* \< 0.05).\
**Abbreviations:** HB, hyaluronic acid and butyric acid; SEM, standard error of the mean; ANOVA, analysis of variance.](jir-10-135Fig2){#f2-jir-10-135}

![HB preserved cellular metabolism after H~2~O~2~-induced oxidative stress.\
**Notes:** MTT assay revealed that oxidative stress reduced cellular metabolism, but this effect was prevented when cells had been pretreated with HB. Negative control cells (not treated with HB or H~2~O~2~) are referred as 100%. Data are given as mean ± SEM of three independent experiments. Statistical analysis: one-way ANOVA (n = 3). Significantly different from H~2~O~2~-treated cells (\**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001).\
**Abbreviations:** HB, hyaluronic acid and butyric acid; SEM, standard error of the mean; ANOVA, analysis of variance; DEVD-CHO, *N*-acetyl-Asp-Glu-Val-Asp-aldehyde.](jir-10-135Fig3){#f3-jir-10-135}

![HB induced p38 phosphorylation and slightly reduced Akt activation.\
**Notes:** (**A**) Western blot analysis on total cell lysates after treatment with HB and H~2~O~2~ and H~2~O~2~ alone. GAPDH was considered as a loading marker. Control was represented by untreated cells (not treated with HB or H~2~O~2~). (**B**) Densitometric analysis of phospho-Akt and GAPDH bands indicated an increased phosphorylation of Akt after oxidative stress induction by H~2~O~2~, but this effect disappeared in HB-pretreated cells. (**C**) Densitometric analysis of phospho-p38 and GAPDH indicated that HB pretreatment induced p38 activation. Data are given as mean ± SEM of three independent experiments. Statistical analysis: one-way ANOVA (n = 3). Significantly different from H~2~O~2~-treated cells (\**p* \< 0.05).\
**Abbreviations:** HB, hyaluronic acid and butyric acid; SEM, standard error of the mean; ANOVA, analysis of variance.](jir-10-135Fig4){#f4-jir-10-135}

![HB treatment immediately upregulated MMP-9 expression and reduced collagen 1 alpha expression.\
**Notes:** (**A**) Collagen 1 alpha gene expression was downregulated after H~2~O~2~ treatment and further decreased in cells that had been pretreated with HB, with a significant difference between the groups at 24 h following H~2~O~2~ treatment. (**B**) Conversely, MMP-9 expression was unaffected by H~2~O~2~ alone, but it tended to be increased in the presence of HB (significant at 24 h). Data were normalized on GAPDH expression; untreated cells (not treated with HB or H~2~O~2~) were used as a control to determine the relative quantification. Statistical analysis: one-way ANOVA (n = 3). Significantly different from H~2~O~2~ (\**p* \< 0.05).\
**Abbreviations:** HB, hyaluronic acid and butyric acid; ANOVA, analysis of variance.](jir-10-135Fig5){#f5-jir-10-135}
